Method for purifying transgenic factor vii
AssigneeLaboratoire Francais Du Fractionnement Et Des Biotechnologies
InventorsDamien Bataille, Michel Nogre
Life of this patent
Estimating the term…
Abstract
An anti-Factor VII affinity ligand that is particularly useful for purifying recombinant human activated Factor VII from transgenic sources. The affinity ligand combined with other orthogonal chromatographic steps allows the preparation of a highly purified FVII solution fully activated free of aggregates with a low percentage of degraded or oxidized FVII forms.
Claims19
A method for purifying transgenic Factor VII (TgFVII) and/or transgenic activated Factor VII (TgFVIIa) from a source biological material, comprising a step of affinity chromatography comprising the steps of:
- (a) contacting a source biological material containing TgFVII and/or TgFVIIa with a ligand which is specific to TgFVII and/or TgFVIIa, under conditions allowing the TgFVII and/or TgFVIIa to bind the ligand, and
- (b) recovering TgFVII and/or TgFVIIa by disrupting in a non destructive way the interaction with said ligand.
Dependencies are inferred from the claim text.